(11beta)-11,21-Dihydroxy-17-(1-oxobutoxy)pregn-4-ene-3,20-dione |
(1S,10S,11S,15S,17S,2R,14R)-17-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyl-5-ox otetracyclo[8.7.0.0<2,7>.0<11,15>]heptadec-6-en-14-yl butanoate |
(1S,2R,10S,11S,14R,15S,17S)-17-HYDROXY-14-(2-HYDROXYACETYL)-2,15-DIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-14-YL BUTANOATE |
[(8S,9S,10R,11S,13S,14S,17R)-10,13-dimethyl-11-oxidanyl-17-(2-oxidanylethanoyl)-3-oxidanylidene-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate |
[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate |
[11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate |
05RMF7YPWN |
11-beta,17-alpha,21-Trihydroxy-4-pregnene-3,20-dione 17-alpha-butyrate |
11-beta,17-alpha,21-trihydroxy-4-pregnene-3,20-dione17-alpha-butyrate |
11|A,17,21-Trihydroxypregn-4-ene-3,20-dione 17-butyrate |
11b,17,21-Trihydroxypregn-4-ene-3,20-dione 17-butyrate |
11beta,17,21-Trihydroxypregn-4-ene-3,20-dione 17-butyrate |
11beta,21-dihydroxy-17alpha-butyryloxy-4-pregnene-3,20-dione |
11beta,21-dihydroxy-3,20-dioxopregn-4-en-17-yl butanoate |
135467-84-4 |
13609-67-1 |
17-O-butyrylcortisol |
4CA-0622 |
609H671 |
A807026 |
AB00052341_02 |
AC-492 |
AC1L1AHF |
AC1L1GE2 |
ACMC-20mvrv |
AJ-47560 |
AKOS015895443 |
Alfason |
AN-15773 |
API0005043 |
AX8134121 |
BC214764 |
BSPBio_003158 |
Bucort |
butanoic acid [(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxy-1-oxoethyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] ester |
Butyric acid hydrocortisone |
CAS-13609-67-1 |
CCG-39923 |
CHEBI:31674 |
CHEMBL1434261 |
CHEMBL1683 |
Cortisol 17-butyrate |
CORTISOL, 17-BUTYRATE |
CS-4474 |
CTK0H7965 |
D01619 |
DivK1c_000743 |
DSSTox_CID_25896 |
DSSTox_GSID_45896 |
DSSTox_RID_81208 |
DTXSID4045896 |
EINECS 237-093-4 |
Epitope ID:119710 |
H-17-B |
H.17B |
HB(sub 17) |
hb(sub17) |
HMS1922O17 |
HMS2093C09 |
HMS2231B16 |
HMS502F05 |
HY-B0983 |
Hycortate |
Hydrocortisone 17-butyrate |
Hydrocortisone 17alpha-butyrate |
hydrocortisone butyrate |
Hydrocortisone Butyrate (Hydrocortisone 17-Butyrate) |
Hydrocortisone butyrate (JP17/USP) |
Hydrocortisone butyrate [USAN:BAN:JAN] |
Hydrocortisone butyrate [USAN:USP:BAN:JAN] |
Hydrocortisone butyrate, United States Pharmacopeia (USP) Reference Standard |
Hydrocortisone-17-butyrate |
Hydrocortisone-17alpha-butyrate |
I06-0576 |
IDI1_000743 |
KBio1_000743 |
KBio2_002131 |
KBio2_004699 |
KBio2_007267 |
KBio3_002658 |
KBioGR_001042 |
KBioSS_002131 |
Lacoid |
Lacoidon |
Laticort |
locoid (TN) |
LS-54996 |
LT00244772 |
MCULE-5041290339 |
MFCD00083364 |
MLS000028716 |
MLS001076086 |
MLS002207122 |
MolPort-003-941-574 |
NCGC00095037-01 |
NCGC00159427-02 |
NCGC00178233-01 |
NCGC00274077-01 |
NINDS_000743 |
NSC-758433 |
NSC758433 |
Opera_ID_188 |
Pharmakon1600-01503273 |
PL000382 |
Pregn-4-ene-3,20-dione, 11,21-dihydroxy-17-(1-oxobutoxy)-, (11-beta)- |
Pregn-4-ene-3,20-dione, 11,21-dihydroxy-17-(1-oxobutoxy)-, (11beta)- |
SBI-0051808.P002 |
SCHEMBL14936050 |
SCHEMBL4695 |
SMR000058859 |
SPBio_001212 |
Spectrum_001651 |
SPECTRUM1503273 |
Spectrum2_001106 |
Spectrum3_001589 |
Spectrum4_000581 |
Spectrum5_001171 |
ST075194 |
Tox21_111397 |
Tox21_111397_1 |
UNII-05RMF7YPWN |
VA11057 |
W-108252 |
ZINC34779372 |
ZINC3977794 |